The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparisons of telemedicine and in-person visits: Utilization, oncology services and satisfaction among patients with breast cancer.
 
Jincong Q. Freeman
No Relationships to Disclose
 
Fangyuan Zhao
No Relationships to Disclose
 
Frederick Matthew Howard
No Relationships to Disclose
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; Cardinal Health; Fujifilm; GE Healthcare; Gilead Sciences; Infinity Pharmaceuticals; ITeos Therapeutics; Merck; OBI Pharma; OncoSec; Sanofi; Seagen
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sun Pharma (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Olufunmilayo I. Olopade
Employment - CancerIQ (I)
Leadership - CancerIQ
Stock and Other Ownership Interests - 54gene; CancerIQ; HealthWell Solutions; Tempus
Consulting or Advisory Role - Tempus
Research Funding - Color Genomics (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - ACS; Susan G. Komen for the Cure
 
Dezheng Huo
No Relationships to Disclose